{"database": "lobbying", "table": "lobbying_activities", "rows": [[2511428, "a72fb33c-dac7-4d2f-a24c-8d54892ac0a2", "Q3", "BRACEWELL LLP", 6837, "NATIONAL BRAIN TUMOR SOCIETY", 2020, "third_quarter", "MED", "work related to the advancement of the Cancer Drug Coverage Parity Act and PCHETA (H.R. 647); Peer-review cancer research; Drug pricing and shortages; COVID-19 Response Issues", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-10-16T14:38:49.650000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2511428"], "units": {}, "query_ms": 14.653479913249612, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}